DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in LLY — ELI LILLY & Co
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in LLY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,161,893,009
+$104,167,066 QoQ
Shares Held
1,263,243
+28.3% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $6,138,982,939 across 11 Drug Manufacturers - General names. LLY ranks #3 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
12,938,604 | $2,551,751,478 | |
| 2 | JNJ |
Johnson & Johnson
|
6,172,828 | $1,508,886,072 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
1,263,243 | $1,161,893,009 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
2,122,979 | $295,879,581 | |
| 5 | ABBV |
AbbVie Inc.
|
1,091,285 | $237,343,571 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,705,178 | $205,115,859 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,163,953 | $70,593,748 | |
| 8 | AMGN |
Amgen Inc
|
186,559 | $65,640,782 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,161,893,009 | 1,263,243 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,057,725,943 | 984,224 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $802,670,659 | 1,051,993 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $908,365,259 | 1,165,273 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,745,838,287 | 2,113,836 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,420,875,264 | 1,840,512 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,016,581,940 | 2,276,206 | Shares | Defined | 2026-05-04 | |
| 2024-06-30 | $1,783,702,714 | 1,970,115 | Shares | Defined | 2026-05-04 | |
| 2024-03-31 | $2,402,993,185 | 3,088,839 | Shares | Sole | 2026-05-04 | |
| 2023-12-31 | $1,616,673,239 | 2,773,405 | Shares | Sole | 2026-05-04 | |
| 2023-09-30 | $1,842,856,501 | 3,430,932 | Shares | Defined | 2026-05-04 | |
| 2023-06-30 | $1,407,478,854 | 3,001,149 | Shares | Defined | 2026-05-04 | |
| 2023-03-31 | $928,332,941 | 2,703,200 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,011,861,487 | 2,765,858 | Shares | Defined | 2023-02-16 | |
| 2022-09-30 | $820,786,465 | 2,538,384 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $740,048,487 | 2,282,480 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,075,641,799 | 3,756,126 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,250,102,110 | 4,525,748 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $755,055,455 | 3,267,931 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $471,225,215 | 2,053,090 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $90,900,070 | 486,565 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $435,489,347 | 2,579,302 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $105,438,049 | 712,323 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $87,185,980 | 531,039 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $64,996,561 | 468,545 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||